Medicamentos en Cardiologia

7/24/2019 Medicamentos en Cardiologia

1/13

!"#$%"&' )*+,-./*01')*-.0,2/' +*

3--,40

50+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

!"#$%$$'(

*+#,"#-,#./

0.1#2#$#3. 45 &/"5$/-,/$#3. 45

(5"','.#./

65-"5(#3.7!865-"5(#3.9 !

:5;"'-/,%/ -5"# 5(,"5L#+#5.,'>"5,5.$#3. ;"#./"#/> M#(#3.

2'""'(/> (5K;54/4 '"/&FN6#/ (54/$#3.>/;+5.,' 45 -5('7

0+#-"/+#./

0.1#2#$#3. 45 &/"5$/-,/$#3. 45

(5"','.#./>#.1#25

"5$/-,/$#3. -'"+5+2"/./.5;"'./&7

!/+2#=. -;545"5D;&/"

.5D/,#M/+5.,5

"5$-5,'"5( 25,/O/4"5.="D#$'( P"5$5-,'"5( 45

(5"','.#./7

65-"5(#3.65-"5(#3. -54#Q,"#$/

6'&'" ?"3.#$'

*.,# /""%,+#$'( C-"'&'.D/$#3. 45& E!F !@54#$/+5.,'(K;5 -"'&'.D;5. 5& E! !@5$&'25+#45> G"'$/"2/R#.5SB#5(D' (T (5"','.#.="D#$'

U/,#D/> &5,/"D#/> (54/$#3.>452#/4> $'.(,#-/$#3.>

2'$/ (5$/> M#(#3. 2'""'(/7

0BVV V5",/./

0.1#2#4'" / &/"5$/-,/$#3. 45

(5"','.#./(5&5$,#M/7 :'/

45('"45. 45 /.(#54/4('$#/&> 45('"45.

4#( 4#/""5/>

/&;$#./$#'.5(F @/"5' !U/,#D/ !?5


2/13

U&;'T5,#./

0.1#2#4'" / &/"5$/-,/$#3. 45

(5"','.#./(5&5$,#M/7 :'/ $'. -'(#2&5 -',5.$#/$#3. 45 (; /$$#3. P]','T#$#4/4> -'" #.1#2#$#3. 45 (; +5,/2'(+' 15-Q,#$'7! 65T,"'+5,'" (5K;54/4 452'$/> 5(,"5L#+#5.,'>4#(+#.;$#3. 45& /-5,#,'

V:?S $5 ,5+2&'"5(>+/"5'(@5.,/&5(S ('+.'&5.$#/>/(,5.#/> #.('+.#'^_S#+-',5.$#/(5T;/&

U&;M'T/+#./

0.1#2#4'" / &/"5$/-,/$#3. 45

(5"','.#./(5&5$,#M/7 :'/


3/13

6_*[ZV)*+,-./*01' )*-.0,2/' +* 3--,40 50+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

@#",/R/-#./

Z(,";$,;"/ ,5,"/$%$$/7Z 5+5(#(>

#.('+.#'

!:5;,"'-5.#/ !*$/,#(#/ !d#-'./,"5+#/

!d#-',5.(#3.'",'(,/,#$/ !Z"#,5+/

+;&,#


4/13

g5.&/-'" #.1#2#$#3. 45 (;

+5,/2'(+' 15-Q,#$'7! d/&'-5"#4'&S

/;+5.,' 45& Q"5/ 2/X'$;"M/ P 4#(+#.;$#3. 45&

/$&/"/+#5.,' 451/&'-5"#4'&> $'. -'(#2&5

-',5.$#/$#3. 45 (;/$$#3. P]' ,'T#$#4/4>-'" #.1#2#$#3. 45 (;

+5,/2'(+' 15-Q,#$'7!V5&5D#./S

-',5.$#/,'T#$#4/4C(%.4"'+5 (5"','.%.5"D#$'F

65"+/,'&3D#$'(SV;4'"/$#3.>5";-$#'.5(

5T/.,5+Q,#$/(7 !?/"4#'M/($;&/"5(S

d#-5",5.(#3.>-/&-#,/$#'.5(7 !^0!S:Q;(5/(> (5K;54/4

45 2'$/>

5(,"5L#+#5.,'>/.'"5T#/> 4#/""5/>M3+#,'(7 !V:?S?5 +/"5'(>

,5+2&'"7

Y;-"'-#'.

0.1#2#4'" 45 "5$/-,/$#3.45 4'-/+#./

.'"5-#.5 #.4;$,'"5( 455.R#+/( 15-Q,#$/(>

#.1#2#4'"5( 45 5.R#+/(15-Q,#$/(> .#$',#./>"#.',/M#"> &5M'4'-/

6'&'" $5"M#$/&>"5/$$#'.5( /&="D#$/(>

d!*> W5"'(,'+%/>/;+5.,' 45 /-5,#,' '

/.'"5T#/> /","/&D#/>#.('+.#' '

('+.'.$#/

?'.,"/#.4#$/4' 5.5-#&5-(#/7

U"#2"'+/&D#/ P +#'/&D' 5(,Q.

"5&/$#'./4/( $'.('+/,#R/$#3. P -'"

5(' (5 ;,#R/.$'+' h


5/13

ZV!*Y0[0a*6ABZV 6Z[ i:0@A)*+,-./*01' )*-.0,2/' +* 3--,40 50+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

?/"2'./,' 45,#'

0.1#25 (;-5"(5.(#2#/4 45"5$5-,'" 6b -'(,(#.Q-,#$'7*&,5"/ ,"/.(-'",5 45 $/,#'.5( 5.$=&;&/( .5"M#'(/( P +;($;/&/"5(>5 #.,5+2&'"> -'"#/

i$#4' g/&-"'#$'

0.$"5+5.,' 45 &/ #./$,#M/$#3. 45&'( $/./&5( 45 ('4#' P $/&$#'7O 0.1#25 &/ ^*Y* ,"/.(/+#./(/ P&/ "5$/-,/$#3. 45 ^*Y* 5. &/(

.5;"'./(7O 0.$"5+5.,' 5. &/$'.$5.,"/$#3. 45 ^*Y* 5. 5&$5"52"'7

Z-#&5-(#/( D5.5"/R/4/(*;(5.$#/(@#'$&'.#/(!"/(,'".' 2#-'&/"

?'.,"/#.4#$/$#3.S Z+2/"/R'

G',5.$#/ 5$/"2/+/R5-#./> &/+',"#D#./>R#4'M;4#./> .#+'4#-#.'>5,'(;T#+#4/>

G/.$"5/,#,#( /D;4/7

5-#('4#'(+#T,'( C5. ;.

4%/ -/(/ 455;


6/13

?/"2/+/R5-#./

Z(,/2#R/ 5& 5(,/4' 45#./$,#M#4/4 45 &'( $/./&5( 45('4#'> &' K;5 1/$5 / &/( .5;"'./(+5.'( 5T$#,/2&5(7G;545 "54;$#" &/ /$,#M#4/4 45&.k$&5' M5.,"/& 45& ,Q&/+'>"54;$#" &/ ,"/.(+#(#3. (#.Q-,#$/' &/ (;+/$#3. 45 &'( 5(,%+;&'(,5+-'"/&5(

Z-#&5-(#/:5;"/&D#/ 45& ,"#D=+#.'ZK;5,"' C@/.#/ Y#-'&/"F0.#$#/&+5.,5 bll +D GA Keb1">/;+5.,/" -'" bll +D]4%/

:' ;(/" 5. 5+2/"/R' C$/,5D'"%/ 6F.# 4;"/.,5 &/ &/$,/.$#/U5.'2/"2#,/&> U'2#/ V'$#/&>!"/(,'".' 45 *.(#54/4^5.5"/R/4/> !A?> ,"/(,'".'( 45&+'M#+#5.,'7

6'&'" 45 5(-/&4/> 4'&'"/24'+#./&> #.('+.#'>('+.'&5.$#/> 2'$/ (5$/> "#.#,#(>,'(>


7/13

YZ:aA60*?ZG0:*V 6TS #.,'T#$/$#3. -'" 25.R'4#/$5-#./> &' K;5 +/( ;(/+'( 5. 5& /.,"/R'&/+ > (#.' (#"M5;(/+'( $&'.R5-/+

[/( 25R'4#/$5-#./( +/( ;,#R/4/(S &'"/$5-/+> /&-"/R'&/+> $&'"/R5-/+!"#$%"&' )*+,-./*01' )*-.0,2/' +* 3--,40 50+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

*$$#3.;&,"/$'",/

Ce j r1F

!"#/R'&/+

:' +5,/2',' /$,#M'765-"#+5 ,'4'( &'(

.#M5&5( 45& ?:VC -'(#2&5+5.,5

/;+5.,/.4' &/-5"+5/2#/4

+5+2"/./ / #'.5( 45$&'"' K;5 /;+5.,/. &/

/$,#M#4/4 45 ^*Y*7

@5$ ,'4'(S _.#'. / "5$5-,'"5(45 ^*Y*7 G',5.$#/4'"5(7

*.(#54/4> -"5+54#$/$#3./.5(,=(#$/> *+.=(#$'(>d#-.3,#$'(O (54/.,5(>

$'.M;&(#'.5(> (T/2(,#.5.$#/ /&$'1'&>"5&/X/.,5 +;($;&/"7

*,/T#/> 4"'s(#.5((>(54/$#L#.> *.('#54/4-(#$'(#(7 ?'. CW/./TF['"#.5,/$5-/+>

['"/R5-/+> C*,#M/.F

#45/& 5. -,5 K;5,#5.5. $'+-"'+#('

45 &/ '

AT/R5-/+

Y5.R'4#/$5-#./#45/& C.'

+5,/2'(+'15-Q,#$'F

Y"'+/R5-/+>C[5T',/.F

U&;.#,"/R5-/+>CB'1P-.'&F

*$$#3.[/"D/

C+/P'" /n1F

?&'./R5-/+ C"#M',"#&F

@5,/2',' /$,#M'7*;+5.,/ #.1#2#$#3. 45

^*Y* -"5(#.Q-,#$/ P"54;$5 "5


8/13

?&'"/R5-/,'>C!"/.R#+> @'45"/.5>

!5.$#&/.> f;(,;+F

@5,/2',' /$,#M'765-"#+5 ,'4'( &'(

.#M5&5( 45& ?:VC -'(#2&5+5.,5

/;+5.,/.4' &/-5"+5/2#/4

+5+2"/./ / #'.5( 45$&'"' K;5 /;+5.,/. &/

/$,#M#4/4 45 ^*Y*7

!"/(,'".'( 45 (;5.' C $'",'4;"/$#3.F

!"/(,'".'( 45 /.(#54/4V%.4"'+5 /.(#'(' 45-"5(#M'

?"#(#( 45 -Q.#$'V,/,;( 5-#&=-,#$'(

@;$1'( -"'$54#+#5.,'(D/(,"'5.,5"'&3D#$'(> &' ;(/.

-/"/ (54/"(57

*&$'1'& P ',"'(45-"5('"5( 45& (.$B# Cg/+F

@5,/2',' /$,#M'7@'4;&/ 5 /.(#'&%,#$' CP/

.' (5 ;(/ ,/.,'F


9/13

0:6_?!ABZV 6Z[ V_ZtA

)*+,-./*01')*-.0,2/' +*

3--,40

50+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

!"/R'4'./

0.1#25 "5$/-,/$#3. 45(5"','.#./ C-5"' .'

:ZF *.,/D'.#(,/"5$-5',"

/& 5.45-"5(#3. 5.43D5./ '5T3D5./7 ?'/4P;M/.,5 5.,"/(,'".'( 45& (;5L'7

:A ;(/" $'. 45-"5('"5( 45& V:?>

/.,#1#(,/+#.#$'(7 [/( #.,5"/$$#'.5(-"#.$#-/&5( $'. ',"'(+54#$/+5.,'( ('.S

*$5,/+#.'45(-5",/"5( .'$,;".'(>+5X'"/ $//4 45 (;5L'

V'+.'&5.$#/ 4#;"./

6#(+#.;$#3. 45&5(,/4' 45 /&5",/*&,5"/$#'.5( 45$'.$#5.$#/?5 +/"5'*+.5(#/> /&;$#./$#3.>-5(/4#&&/(g5",#D'6#/""5/652#/4 +;($;&/"


10/13

a'-#$&'./

*.Q&'D' YR7 65-"#+5,'4'( &'( .#M5&5( 45&

?:V C

-'(#2&5+5.,5/;+5.,/.4' &/-5"+5/2#/4

+5+2"/./ / #'.5( 45$&'"' K;5 /;+5.,/. &/

/$,#M#4/4 45 ^*Y*7

+/.5X' 45 &'( ,"/(,'".'( 5.5& "#,+' 45& (;5L' P ,'4/(&/(


11/13

*:!0GV0?u!0?AV!vG0?AV

)*+,-./*01' )*-.0,2/' +*

3--,4050+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

*.,#-(#$3,#$'(!%-#$'(

d/&'-5"#4'&

*.,/D'.#(,/ 45"5$5-,'"5( 45

4'-/#./ 6e P 6b 5.$5"52"'> B5-"#+5

/$,#M/$#3. "5,#$;&/" P"/$#3. 45

1'"+#./(1#-',Q&/+#$/( 5

1#-' ,"5+5.(F

Z(,/4'( -(#$3,#$'( /D;4'(P $"3.#$'( C45"#'

-/"/.'#45 P5(K;#R'#.$&;P5.4' /&$'1'&>

1#-.3,#$'(> (54/.,5( '/./&D=(#$'( -',5.,5(7

G;545 /&,5"/" 5& 54=2#&+5.,5 6b]6I7

*D#,/$#3. P 5T$#,/$#3.-(#$'+',"#R> 5(,/4'(45-"5(#M'(> -(#$'(#(

/D;4/ P $"3.#$/7*.(#54/4 P ,"/(,'".'( 45&

(;5L'*&D#/( 0.,5.(/(

0.$"5+5.,/ &'( 5 5"5,#.'-/,%/

-#D+5.,/"#/>/D"/.;&'$#,'(#(>

&5;$'-5.#/7

&5M'+5-"'R#./-"'4;$5 +;$1/(54/$#3. C(#"M5

-/"/ ,"/,/+#5.,'$;/.4'

25.R'4#/$5-#./(.'


12/13

*:!0GV0?u!0?AV *!vG0?AV

)*+,-./*01' )*-.0,2/' +* 3--,40 50+,-.-,'0*2 501*%.--,'0*2 67*-1'2 3+8*%2'2 91%'2

?&'R/-#./

!#5.5 2/X/ / $'.(#.$'-5(> ,/K;#$/"4#/>

1#-',5.(#'.> $/+2#'( 5.5& Z?^> ./;(5/(> M'+#,'>

&5;$'-5.#/>D"/.;&'$#,'-5.#/>

/D"/.;&'(#,'(#( P 45+5.$#/ ' 4#(,5+2&'"> #.$'.,#.5.$#/F

6#($#.5(#/( ,/"4%/(>V'+.'&5.$#/

Y'$/ (5$/> *(,5.#/d#-',5.(#3. -'(,;"/& P

+/"5'(> *;+5.,' 45-5('> Z(,"5L#+#5.,'>*;+5.,' /;+5.,' 45 -5('

*$/,#$#/> 2'$/ (5$/>(54/$#3.> #.('+.#'>+/"5'> 1#-',5.(#3.

'",'(,Q,#$/

*_@Z:!A 6Z

GZVA

*"#-#-"/R'&*D'.#(,/ -/"$#/ 45 6b PcOd,e*> *.,/D'.#(,/ 45

"5$-5,'" cOd!b*7

Z(K;#R'


13/13

*$,#M#4/4 45 2&'K;5'/&5 @/.#/ 2#-'&/">-/"/(#,'(#( 45&;(#'./&>

(%.,'+/( -(#$3,#$'(7 *D"5#(3.*&R15#+5"> /D"5(#3.

,/"(,'".'( 45 $'.4;$,/7

?/"2/+/R5-#./> '-#Q$5'(>/.,#1#(,/+%.#$'( P25.R'4#/$5-#./(C*;+5.,' 45&/ (54/$#3.FU&;'T5,#./> -/"'T5,#./>M5"/-/+#&'> 1#-5"-"'&/$,#.5+#/ 5.

-54#/,"%/7

*_@Z:!A 6ZGZVA

Medicamentos en Cardiologia

Documents

Transcript of Medicamentos en Cardiologia